|
| Xpert-positive (%) | Xpert-negative (%) | Rifampicin resistance (%) |
| New cases |
|
|
|
| Smear-positive | 283 (100) | 0 | 27 (9.5) |
| Smear-negative | 14 (1.6) | 879 (98.4) | 0 |
| Previously treated cases |
|
|
|
| Smear-positive | 158 (100) | 0 | 73 (46.2) |
| Smear-negative | 3 (4.2) | 67 (95.8) | 2 (2.8) |